Ideaya Biosciences

是其中之一......

• Russell 3000;
• TOB Iconic 10,000.

Ideaya Biosciences 是一家在股票代码 IDYA (US) 下上市的公司。

查看带有其 19 名主要高管的组织结构图

Ideaya Biosciences 搜索最多的简介

• Yujiro Hata, Chief Executive Officer and Director
• Susan Kelley, Director
• Garret Hampton, Director

高管在Ideaya Biosciences变化

• Douglas Snyder已作为Senior Vice President and General Counsel加入公司  (新闻发布的2024九月19号).
• Jason Throne, Chief Legal Officer, 将于 20247月10 退休  (新闻发布的2024六月27号).
• Daniel Simon已作为Chief Business Officer加入公司  (新闻发布的2024五月29号).

创建提醒
跟踪 Ideaya Biosciences 的高管变动

Ideaya Biosciences 拥有 2,316 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。

Popular M&A news in 生物技术

• AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
• Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
• TuHura Biosciences and Kintara Therapeutics have merged  (公布2024十月20号)..

生物技术 行业的其他推荐联系人

• Scholar Rock 企业 Kristina Burow - Director
• UroGen 企业 Fred Cohen - Director
• Adaptimmune Therapeutics 企业 Ali Behbahani - Non-Executive Director

了解更多有关生物技术行业的信息 >

Ideaya Biosciences 的最新新闻稿

• Investor Relations | IDEAYA Biosciences - News ReleasesBack ButtonSearch IconFilter Icon
• IDEAYA to Participate in Upcoming November 2020 Investor Relations Events - IDEAYA Biosciences
• IDEAYA Announces Partnership With The Broad Institute And Advancement Of Synthetic Lethality Programs And Platform - IDEAYA Biosciences
• IDEAYA and Pfizer Expand Clinical Trial Collaboration and Supply Agreement to Evaluate Clinical Combination of IDE196 and Crizotinib in Solid Tumors Harboring GNAQ or GNA11 Mutations - IDEAYA Biosciences
• IDEAYA to Participate in Upcoming September 2020 Investor Relations Events - IDEAYA Biosciences
• IDEAYA Biosciences, Inc. Reports Second Quarter 2020 Financial Results and Provides Business Update - IDEAYA Biosciences
• IDEAYA Announces HSR Clearance of GSK Strategic Partnership in Synthetic Lethality and Closing of Glaxo Group Equity Investment - IDEAYA Biosciences
• IDEAYA Announces IDE196 Program Update and Clinical Protocol Criteria Met for Cohort Expansion in Skin Melanoma for Phase 2 GNAQ/11 Basket Trial - IDEAYA Biosciences
• IDEAYA to Participate in Fireside Chat at BTIG Biotechnology Conference and Wedbush PacGrow Healthcare Conference on August 11 and 12, 2020 - IDEAYA Biosciences
• IDEAYA Biosciences Doses First Patient in a Phase 1 Combination Study of IDE196 and Binimetinib, a MEK Inhibitor - IDEAYA Biosciences
• View more press releases Close

关于 Ideaya Biosciences 的社交媒体

• Ideaya Biosciences 在 维基百科、谷歌新闻 和 雅虎财经
• Ideaya Biosciences 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Yujiro Hata

致电Ideaya Biosciences，电话：+1 650...

查看组织结构图

Register to receive your alert

报告错误